A carregar...
Novel, Biocompatible, Disease Modifying Nanomedicine of VIP for Rheumatoid Arthritis
Despite advances in rheumatoid arthritis (RA) treatment, efficacious and safe disease-modifying therapy still represents an unmet medical need. Here we describe an innovative strategy to treat RA by targeting low doses of vasoactive intestinal peptide (VIP) self-associated with sterically stabilized...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3563715/ https://ncbi.nlm.nih.gov/pubmed/23211088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp300539f |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|